此前研究提出，DOPA 脱羧酶（DOPA decarboxylase，DDC，也叫芳香族 L - 氨基酸脱羧酶 Aromatic - L - amino acid decarboxylase，AADC）可能是 LBDs 有前景的脑脊液（cerebrospinal fluid，CSF）生物标志物，不过血浆 DDC 水平的研究结果却不一致，这使得血浆 DDC 作为 LBDs 潜在生物标志物 ...

Lund University researchers have discovered a biomarker, DOPA decarboxylase (DCC), that may help diagnose Parkinson’s disease and similar disorders by indicating dopamine system damage in the brain.

In a significant stride towards early detection and prognosis of Parkinsonian disorders, a recent study published in the Nature Aging Journal revealed the potential of cerebrospinal fluid levels of ...

In participants who had Parkinson’s disease or DLB, the cerebrospinal fluid had much higher levels of DOPA decarboxylase – an enzyme that helps with the production of dopamine – compared ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

V1512 (melevodopa/carbidopa) is an effervescent tablet formulation for the treatment of Parkinson's disease. V1512 combines carbidopa and methyl ester of levadopa (L ...

Background: Increasing evidence indicates that L-dopa decarboxylase (DDC), which mediates aberrant amino acid metabolism, is significantly associated with tumor progression. However, the impacts of ...

For this study, Gregg and his colleagues focused on a gene called dopa decarboxylase, which neurons need to manufacture dopamine, serotonin and noradrenaline. These are all neurotransmitters ...